Drug General Information (ID: DDI4LOGTQR)
  Drug Name Bisacodyl Drug Info Fludeoxyglucose (18F) Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Laxatives Diagnostic Radiopharmaceuticals
  Structure

 Mechanism of Bisacodyl-Fludeoxyglucose (18F) Interaction (Severity Level: Moderate)
     Interference of cell/tissue uptake Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Bisacodyl Fludeoxyglucose (18F)
      Mechanism Effect fludeoxyglucose F18 diagnostic test results Fludeoxyglucose F18
      Key Mechanism Factor 1
Factor Name Pharmacokinetics
Factor Description Alters the distribution of the drug, leading to changes in the plasma concentration of the drug and affecting the pharmacological effects.
      Mechanism Description
  • Interference of cell/tissue uptake of Fludeoxyglucose (18F) by Bisacodyl 

Recommended Action
      Management Clinicians should be aware of possible diagnostic interference associated with the following medications: colony-stimulating factors may increase uptake in spleen and bone marrow glucose-induced hyperglycemia may interfere with uptake dopamine and insulin may decrease myocardial and tumor cell uptake laxative-induced intestinal muscle activity and/or irritation may increase intestinal uptake.

References
1 Cerner Multum, Inc. "Australian Product Information.".
2 Multum Information Services, Inc. Expert Review Panel.
3 Product Information. Metamucil (psyllium). Procter and Gamble Pharmaceutic, Cincinnati, OH.